Author:
Mirzazadeh Ali,Hosseini-Hooshyar Samira,Shahesmaeili Armita,Sharafi Heidar,Shafiei Mohammad,Zarei Jasem,Mousavian Ghazal,Tavakoli Fatemeh,Ghalekhani Nima,Shokoohi Mostafa,Khezri Mehrdad,Mehmandoost Soheil,Shojaei Mohammad Reza,Karamouzian Mohammad,Briceno Alya,Morris Meghan D.,Alavian Seyed Moayed,Haghdoost Ali-Akbar,Sharifi Hamid,Page Kimberly A.
Subject
Health Policy,Medicine (miscellaneous)
Reference38 articles.
1. Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country;Alam-Mehrjerdi;Asian Journal of Psychiatry,2015
2. Willingness to receive treatment for hepatitis C among injecting drug users on methadone program: Implications for education and treatment;Alam-Mehrjerdi;Addiction & Health,2016
3. An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study;Alavi;International Journal of Drug Policy,2019
4. Recommendations for the clinical management of hepatitis C in Iran: A consensus-based national guideline;Alavian;Hepatitis Monthly,2016
5. Profile of people who inject drugs in Tehran, Iran;Amin-Esmaeili;Acta Medica Iranica,2016
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献